Yi Xing, PhD
Skip to content
Postdoctoral Fellow in Statistics and Developmental Biology - Stanford University, Stanford, CA
PhD in Molecular Biology, Bioinformatics - University of California Los Angeles, Los Angeles, CA
Francis West Lewis Endowed Chair
Executive Director, Center for Computational and Genomic Medicine
Professor of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania
Computational biology and genomics of RNA processing and regulation
Xin R, Gao Y, Gao Y, Wang R, Kadash-Edmondson KE, Liu B, Wang Y, Lin L, Xing Y. isoCirc catalogs full-length circular RNA isoforms in human transcriptomes. Nat Commun 12(): 266, 2021, PMID:33436621.
Demirdjian, L., Xu, Y., Bahrami-Samani, E., Pan, Y., Stein, S., Xie, Z., Park, E., Wu, Y. N., Xing, Y. Detecting Allele-Specific Alternative Splicing from Population-Scale RNA-Seq Data. Am J Hum Genet 107(3): 461-472, 2020.
Zhang, Y., Yang, H. T., Kadash-Edmondson, K., Pan, Y., Pan, Z., Davidson, B. L., Xing, Y. Regional Variation of Splicing QTLs in Human Brain. Am J Hum Genet 107(2): 196-210, 2020.
Phillips John W, Pan Yang, Tsai Brandon L, Xie Zhijie, Demirdjian Levon, Xiao Wen, Yang Harry T, Zhang Yida, Lin Chia Ho, Cheng Donghui, Hu Qiang, Liu Song, Black Douglas L, Witte Owen N, Xing Yi. Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.. Proceedings of the National Academy of Sciences of the United States of America 117(10): 5269-5279, 2020, PMID:32086391.
Zhang Zijun, Pan Zhicheng, Ying Yi, Xie Zhijie, Adhikari Samir, Phillips John, Carstens Russ P, Black Douglas L, Wu Yingnian, Xing Yi. Deep-learning augmented RNA-seq analysis of transcript splicing. Nat Methods 16(4): 307-310, 2019, PMID:30923373.
Park E, Pan Z, Zhang Z, Lin L, Xing Y. The expanding landscape of alternative splicing variation in human populations. Am J Hum Genet 102(1): 11-26, 2018, PMID:29304370.
Molinie B*, Wang J*, Lim KS, Hillebrand R, Lu ZX, Wittenberghe NV, Howard BD, Daneshvar K, Mullen AC, Dedon P, Xing Y*, Giallourakis CC*. m(6)A-LAIC-seq reveals the census and complexity of the m(6)A epitranscriptome. Nat Methods 13(8): 692-698, 2016, PMID:27376769.
Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, Zhou Q, Xing Y. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci USA 111(51): E5593-E5601, 2014, PMID:25480548.
Batista PJ, Molinie B , Wang J, Qu K, Zhang J, Li L, Bouley DM, Lujan E, Haddad B, Daneshvar K, Carter AC, Flynn RA, Zhou C, Lim KS, Dedon P, Wernig M, Mullen AC, Xing Y*, Giallourakis CC*, Chang HY*. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15(6): 707-719, 2014, PMID:25456834.
Xing Y, Lee C. Alternative splicing and RNA selection pressure--evolutionary consequences for eukaryotic genomes. Nat Rev Genet 7(7): 499-509, 2006, PMID:16770337.
2015-2016, Rose Hills Foundation Scholar
2015-present, Oversea Expert, Chinese Academy of Sciences
2013-2015, Alfred P. Sloan Research Fellowship
2011, Senior Visiting Fellow, UCLA Institute for Pure and Applied Mathematics
2010-2012, Basil O'Connor Starter Scholar Research Award, March of Dimes Foundation
2009-2012, Junior Faculty Grant, Edward Mallinckrodt, Jr. Foundation
2006, Finalist, Walter M. Fitch Prize, Society for Molecular Biology and Evolution
2006, Award for Outstanding Self-Financed Students, Chinese Government
2005-2006, Dissertation Year Fellowship, University of California Los Angeles
2005, Amgen Dissertation Award, Molecular Biology Institute, University of California Los Angeles
2005, Student Fellow Travel Award, RNA Society
2010-present, Society for Molecular Biology and Evolution (SMBE)
2006-present, International Society of Computational Biology (ISCB)
2006-present, American Society of Human Genetics (ASHG)
2005-present, RNA Society
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.